(19)
(11) EP 3 365 819 A2

(12)

(88) Date of publication A3:
03.08.2017

(43) Date of publication:
29.08.2018 Bulletin 2018/35

(21) Application number: 16858475.3

(22) Date of filing: 22.10.2016
(51) International Patent Classification (IPC): 
G06F 19/16(2011.01)
C07D 413/12(2006.01)
C07D 405/14(2006.01)
C07D 231/56(2006.01)
C07D 495/04(2006.01)
C07D 279/16(2006.01)
A61K 31/538(2006.01)
A61K 31/427(2006.01)
A61K 31/167(2006.01)
A61K 31/513(2006.01)
A61K 31/4162(2006.01)
C07D 265/36(2006.01)
C07D 309/34(2006.01)
C07D 417/12(2006.01)
C07D 405/12(2006.01)
C07D 249/12(2006.01)
A61K 31/351(2006.01)
A61K 31/4196(2006.01)
A61K 31/18(2006.01)
A61K 31/416(2006.01)
A61K 31/4025(2006.01)
(86) International application number:
PCT/ZA2016/050042
(87) International publication number:
WO 2017/070719 (27.04.2017 Gazette 2017/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 22.10.2015 ZA 201507849

(71) Applicant: Mangosuthu University Of Technology
4031 Durban (ZA)

(72) Inventor:
  • GUMEDE, Njabulo Joyfull
    4004 Durban (ZA)

(74) Representative: Allen, Matthew Emmerson 
ALLEN IP Limited 3 Windsor Terrace Hagley Road
Birmingham B16 8UH
Birmingham B16 8UH (GB)

   


(54) PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1